Board Certifications

  • Internal Medicine
  • Endocrinology, Diabetes, and Metabolism

Area of Expertise

  • Diabetes Treatment



Ohio State University Wexner Medical Center
Endocrinology, Diabetes, and Metabolism
Columbus, OH


MedStar Georgetown University Hospital
Internal Medicine
Washington, DC


Yale New Haven Hospital
Internal Medicine
New Haven, CT

Medical School

University of Maryland School of Medicine
Doctor of Medicine
Baltimore, MD

Undergraduate School

University of Virginia
Bachelor of Arts
Charlottesville, VA

Hospitals Affiliated With

Greater Baltimore Medical Center
University of Maryland St. Joseph Medical Center

Professional Association

American Association of Clinical Endocrinologists (AACE)


“A Real-world Study of Treatment Patterns and Outcomes in US Managed-Care Patients With Type 2 Diabetes Initiating Injectable Therapies.” Diabetes, Obesity & Metabolism (2016): Wei W, Buysman E, Grabner M, Xie L, Brekke L, Ke X, Chu JW, Levin PA.

“Clinical and Economic Outcomes Associated With the Timing of Initiation of Basal Insulin in Patients With Type 2 Diabetes Mellitus Previously Treated With Oral Antidia…” Clinical Therapeutics (2016): Levin P, Zhou S, Durden E, Farr AM, Gill J, Wei W.

“Health Outcomes Associated with Initiation of Basal Insulin After 1, 2, or ≥ 3 Oral Antidiabetes Drug(s) Among Managed Care Patients with Type 2 Diabetes.” Journal of Managed Care & Specialty Pharmacy (2015): Levin PA, Zhou S, Gill J, Wei W.

Academic Appointment

University of Maryland School of Medicine
Clinical Associate Professor


Dr. Levin is board certified in Endocrinology and Internal Medicine, and a graduate of the University of Maryland School of Medicine. He received internship and residency training at Yale Medical Center Hospitals and Georgetown University Hospital. His fellowship training was at Ohio State University Hospital and NIH. Dr. Levin is a Clinical Associate Professor at the University of Maryland School of Medicine. He has a longstanding involvement in diabetes and directs a diabetes treatment center. Dr. Levin has also been active in diabetes clinical research and has been an NIH Principal Investigator for the DCCT diabetes trial. He has been a principal investigator for studies in inhaled insulins, new oral agents, and glucose sensors, and has more than 30 publications.